South Korean battery maker LG Energy Solution Ltd. shipped 26.4 gigawatt-hour (GWh) equivalents of electric vehicle (EV) batteries in the first 11 months of the year to account for 22.6 percent of the global market and be ranked as the world's second-biggest supplier.
Other South Korean players Samsung SDI Co. and SK Innovation Co. took were fourth and fifth places.
The combined market share by the three South Korean battery makers doubled to 33.9 percent from last year.
LG Energy Solution spun off from LG Chem Ltd. earlier this month.
China's CATL supplied 24.4 GWh equivalents for a 24.2 global market share, thereby maintaining its leading position.
The third spot went to Japan's Panasonic, which had a 19.2 percent share.
LG, CATL, and Panasonic all supply lithium-ion batteries to Tesla, the world's No. 1 EV maker.
Samsung SDI supplies its batteries to Audi and BMW, while SK Innovation batteries power Kia Motors and Mercedes Benz.


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



